UK markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
30.65-0.86 (-2.73%)
As of 3:22PM EDT. Market open.

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
http://www.elanco.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees6,000

Key executives

NameTitlePayExercisedYear born
Mr. Jeffrey N. SimmonsPres, CEO & Director2.27MN/A1967
Mr. Todd S. YoungExec. VP & CFO1.07MN/A1972
Mr. David S. KinardExec. VP of HR722.58kN/A1967
Mr. Aaron L. SchachtExec. VP of Innovation, Regulatory & Bus. Devel.724.45kN/A1967
Mr. David Alan UrbanekExec. VP of Manufacturing & Quality643.43kN/A1967
Mr. James M. MeerVP & Chief Accounting OfficerN/AN/A1970
Mr. Chris KeeleySr. VP & Chief Information OfficerN/AN/AN/A
Ms. Julie LawlessSr. VP of Corp. Affairs & Admin.N/AN/AN/A
Mr. Jim GreffetHead of Investor RelationsN/AN/AN/A
Mr. Michael-Bryant Hicks Esq.Exec. VP, Gen. Counsel & Corp. Sec.N/AN/A1975
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals. It offers companion animal disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production. The company sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. The company has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine; and strategic alliance with the Purdue University and Purdue Research Foundation. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Corporate governance

Elanco Animal Health Incorporated’s ISS governance QualityScore as of 31 October 2019 is 8. The pillar scores are Audit: 2; Board: 9; Shareholder rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.